TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
BSX

Boston Scientific Corp

Healthcare · Medical Devices

42.00$ +1.1% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Cash Flow

Boston Scientific Corp (BSX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 1,474 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow BSX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
-31 466 -7.0 297 452 872 193 -403 501 19 350 292 502 692 -77 269 643 673 284 643 465 478 -58 306 471 807 190 658 698 957 164 813 1,002 1,456 541 1,286 1,343 1,364 348 1,474 4,529
204 213 204 208 210 222 209 216 224 245 229 234 255 293 277 275 282 289 268 263 272 290 274 284 284 294 285 298 300 313 304 311 636 348 325 336 342 365 351 355 1,413
29 29 30 32 – 128 36 – – 140 36 – – 157 42 46 40 42 47 47 51 49 52 55 58 55 55 60 59 59 63 195 -61 69 74 75 79 71 83 87 320
29 38 30 32 34 154 36 32 36 -108 36 38 42 196 42 46 40 77 -2.0 -55 -73 155 278 114 213 -195 98 140 70 – – – – – – – – – – – –
17 -347 -116 -614 -272 -129 924 84 -287 -1,529 3,012 -271 -891 -393 -580 18 320 -117 -353 248 -211 -35 -682 -353 -304 334 -523 -14 -176 -57 -743 -209 166 324 -678 233 44 155 -915 74 -642
71 167 140 87 102 79 163 83 112 106 91 178 143 186 102 95 150 159 75 106 107 266 131 105 172 200 121 206 206 267 245 155 304 293 187 190 181 351 177 195 904
-205 -532 -140 -479 -102 -289 -173 -491 -662 -595 -410 -620 -3,962 -49 -76 -59 -129 -147 71 -133 -1,207 -461 -1,574 -29 -225 -2,011 -484 -840 -197 -1,053 -285 -271 -1,427 -3,704 -500 -1,126 -502 -512 -591 -1,956 -3,561
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – 14 14 14 14 14 14 14 14 13 14 14 14 13 14 14 28 17 0.0 0.0 23 0.0 – – – – – – –
35 3.0 33 11 35 6.0 38 15 41 7.0 53 10 50 10 42 1,956 59 -535 18 38 64 110 52 6.0 -59 136 63 27 165 119 80 – -63 230 115 147 262 282 – -2,000 –
60 60 31 322 -160 -70 -848 1,707 124 422 2,141 305 1,338 -990 346 -835 -250 -260 – 60 60 60 60 -70 -155 37 37 37 -41 – – – 0.0 189 247 -314 -215 -209 -259 1,662 979
34 28 -15 332 -139 -68 130 726 151 425 2,127 256 1,314 -724 256 1,105 -249 -819 -95 2.0 6.0 -8.0 -6.0 -344 -199 1.0 -69 43 16 15 1,569 24 7.0 214 233 -340 -104 -184 -260 -410 -958
-201 -41 -160 446 659 332 151 -174 -14 -148 2,067 -73 -2,147 -69 95 1,316 266 -287 258 642 -739 11 -1,639 -63 42 629 -363 -143 512 -77 1,441 566 -413 -2,043 313 -178 730 672 -521 -890 -9.0
-102 299 -147 210 350 793 30 -486 389 -87 259 114 359 506 -179 174 493 514 209 537 358 212 -189 202 298 607 69 452 492 690 -81 658 698 1,163 354 1,096 1,162 1,013 171 1,279 3,625

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?